Efficacy and Safety of Romiplostim in Adult Subjects With Persistent or Chronic Immune Thrombocytopenia (ITP)
Clinical trial NCT02868099 · COMPLETED
Trial details
- NCT number
- NCT02868099
- Sponsor
- Kyowa Kirin China Pharmaceutical Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-09-01
- Primary completion
- 2017-02-01
- Enrollment
- 203
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.